High Content Screening Market worth $615.8 Million by 2018

Tuesday 18 February 2014, Amsterdam

High Content Screening Market worth $615.8 Million by 2018
The new report, available on ASDReports on High Content Screening analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW).

This report studies the global high content screening market over the forecast period of 2013 to 2018. The global high content screening market was valued at an estimated $362.2 million in 2013 and is expected to reach $615.8 million by 2018, growing at a CAGR of 11.2% from 2013 to 2018.

Enhanced accuracy of cell imaging and analysis systems helps in reducing the drug discovery time period and costs, which is a major factor driving the growth of this market. Furthermore, the increasing use of HCS in toxicity studies in the early phase of drug discovery is another factor that propels the growth of this market. Government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asian region, are also major reasons for the high growth of this market. Based on HCS products, the instruments market commanded the largest share of 43% in 2013. However, the HCS software market is poised to grow at the highest CAGR from 2013 to 2018.

Based on geography, the global high content screening market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the various collaborations among prominent players for developing and marketing new products in the market.

The major players in the high content screening market include Thermo Fisher Scientific (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology (U.S.), Genedata AG (Switzerland), Merck KGaA (Germany), Thorlabs, Inc. (U.S.), and Yokogawa Electric Corporation (Japan), among others.
High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

Publish date : February 2014
Report code : ASDR-98077
Pages : 151

ASDReports.com contact: S. Koomen

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216

 back to News